(b) lnc‐ITSN1‐2 inhibited the anti‐angiogenesis effect of miR‐107, miR‐125a, and miR‐146a to increase the alteration of vascular structure, thereby increasing disease severity in AIS patients.27, 28. The gene discussed is ITSN1; the disease is androgen insensitivity syndrome.